| Followers | 70 |
| Posts | 1643 |
| Boards Moderated | 1 |
| Alias Born | 01/27/2012 |
Saturday, May 19, 2012 12:31:01 AM
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=74684032
http://investorshub.advfn.com/boards/replies.aspx?msg=74684032
It's really all about your tolerance to risk...I'd be lying if I said this isn't a risk, but usually the most reward requires the greatest risk. I'd say before you hit that buy button, you should read everything you can get your hands on about the company. Lots of info right here but don't use IHUB as an exclusive source of information. Bottom line...you have to feel comfortable with your investment and you also have to be willing to accept the consequences of either waiting a long term to see gains or losing your investment altogether. I personally feel confident and am willing to wait as long as it takes, but again I'd be lying if I said I wasn't a little nervous...Hard not to be when your investment is worth about half of what you have invested. LOL But, I refuse to sell at a loss...so that only means one thing. Lose everything or wait until I have gains. Good luck and best wishes.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
